Program Structure

Module 1: Introduction to Nanobiotechnology in Medicine

• Why nanoscale matters: surface area, transport, cellular uptake, and bio-distribution concepts.
• Key applications: targeted delivery, controlled release, imaging contrast, and point-of-care diagnostics.
• Translational constraints: stability, manufacturability, cost, and regulatory expectations (overview).
• Defining success: efficacy signals, safety signals, and measurable design KPIs.

Module 2: Biological Barriers and Targeting Principles

• Barriers to delivery: bloodstream stability, immune clearance, tissue penetration, and cellular uptake.
• Passive vs active targeting: size effects, microenvironment concepts, ligand targeting overview.
• Protein corona and bio-identity: how surfaces influence biological behavior (conceptual).
• Design tradeoffs: targeting vs toxicity, stability vs release, and circulation time vs clearance.

Module 3: Nanocarriers for Drug Delivery (Platforms and Tradeoffs)

• Lipid-based systems: liposomes and lipid nanoparticles (LNPs) overview and use-cases.
• Polymeric nanoparticles: biodegradable polymers, micelles, and nanogels (conceptual).
• Inorganic nanostructures: gold, silica, iron oxide—key properties and safety considerations (overview).
• Hybrid systems: combining materials for multi-functional delivery and imaging.

Module 4: Controlled Release and Stimuli-Responsive Systems

• Release mechanisms: diffusion, degradation, and triggered release (high-level).
• Stimuli triggers: pH, temperature, enzymes, redox environment, and light (conceptual).
• Designing for kinetics: burst release vs sustained release and how to evaluate profiles.
• Practical limitations: variability across patients/tissues and robustness requirements.

Module 5: Surface Functionalization and Bioconjugation Concepts

• Why surface chemistry matters: stability, targeting, stealth, and biocompatibility.
• Ligands and targeting moieties: antibodies, peptides, aptamers (conceptual overview).
• PEGylation and alternatives: circulation time and immune interactions (overview).
• Quality concerns: batch consistency, binding performance, and long-term stability.

Module 6: Nano-Enabled Diagnostics and Biosensing

• Diagnostics landscape: lab-based vs point-of-care; sensitivity/specificity and limit-of-detection concepts.
• Nano-biosensors: plasmonics, electrochemical nanointerfaces, and fluorescence enhancement concepts.
• Lab-on-chip concepts: microfluidics overview and integration with nano-sensing.
• Sample-to-answer workflow thinking: sample prep constraints and usability.

Module 7: Nano-Imaging and Theranostics (Conceptual)

• Imaging modalities overview: MRI/CT/optical/ultrasound and how nano-agents can enhance contrast.
• Theranostics concept: combining therapy + diagnostics for feedback-driven interventions.
• Signal interpretation: background noise, biodistribution effects, and quantification challenges.
• Safety-by-design: dose, clearance pathways, and long-term considerations.

Module 8: Characterization, Stability, and Quality-by-Design (QbD)

• Key characterization metrics: size distribution (DLS), morphology (TEM/SEM), surface charge (zeta), and concentration.
• Drug loading and encapsulation efficiency concepts; release profile measurement logic.
• Stability: aggregation, leakage, oxidation, and storage condition effects.
• QbD mindset: critical quality attributes (CQAs) and control strategies (overview).

Module 9: Translation, Safety, and Regulatory Awareness

• Toxicity considerations: immune responses, off-target accumulation, and material-specific risks (overview).
• Manufacturing scale-up: reproducibility, sterile processing awareness, and supply chain constraints.
• Regulatory landscape awareness: documentation, validation, and risk management mindset.
• Responsible communication: differentiating concept validation vs clinical readiness.

Final Project

• Create a Nano-Enabled Drug Delivery and Diagnostics Blueprint for a selected application.
• Include: unmet need, target biology (high-level), platform choice, design KPIs, characterization plan, safety considerations, and translational roadmap.
• Example projects: nanoparticle delivery concept for an antimicrobial strategy, nano-biosensor concept for early biomarker detection, theranostic design blueprint, or a point-of-care nano-enabled diagnostic workflow for a community health setting.